Company · CIK 0001043873
NOVADEL PHARMA INC
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0000930413-12-001712 · 55.9 KBSEC(opens sec.gov)
- SC 13D/ANOVADEL PHARMA INC0000932440-12-000064 · 223.3 KBSEC(opens sec.gov)
- 8-KCurrent report0000930413-12-000552 · 46.6 KBSEC(opens sec.gov)
- 8-KCurrent report0000930413-12-000426 · 13.4 KBSEC(opens sec.gov)
- 8-K/ANOVADEL PHARMA INC0000930413-12-000409 · 19.3 KBSEC(opens sec.gov)
- 8-KCurrent report0000930413-12-000239 · 53.8 KBSEC(opens sec.gov)
- 8-KCurrent report0000930413-12-000215 · 181.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001043873-11-000079 · 40.1 KBSEC(opens sec.gov)
- 8-KCurrent report0001043873-11-000077 · 184.8 KBSEC(opens sec.gov)
- 10-QQuarterly update0001193125-11-290188 · 1.7 MBSEC(opens sec.gov)
Insiders
- Abd El-Shafy MohammedVP, Pharmaceutical Development
- Baric Mark JDirector
- Bergstrom David HChief Operating Officer
- BIOMEDICAL INVESTMENT GROUP LLCJoint Filer
- Bonney Thomas EDirector
- Cohen BarryVP, Product & Bus Dev
- FRYDMAN JEAN WVP & General Counsel
- HAMILTON WILLIAM F PHDDirector
- Johnson Craig ASr. VP, CFO and Secretary
- KESSEL LARRYDirector
Tickers
No tickers on record.
Addresses
business
1200 ROUTE 22 EAST SUITE 2000
BRIDGEWATER, NJ, 08807
mailing
1200 ROUTE 22 EAST SUITE 2000
BRIDGEWATER, NJ, 08807
Former names
- FLEMINGTON PHARMACEUTICAL CORP2002-10-03
Same industry